PMGC Holdings Inc. announced on March 28, 2025, that it has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (SEC). The report is available on the SEC’s website.
The company stated its dedication to innovative solutions and delivering long-term value for its shareholders. As part of its strategic growth initiatives, PMGC has engaged in an active search for acquisition opportunities involving operating businesses and assets.
These potential acquisitions are targeted to drive meaningful revenue growth and enhance shareholder value. PMGC Holdings operates as a diversified holding company with subsidiaries including Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.